Shandong Weigao Group Medical Polymer Company Limited (FRA:UK2)

Market Cap	3.41B
Revenue (ttm)	1.73B
Net Income (ttm)	273.49M
Shares Out	n/a
EPS (ttm)	0.06
PE Ratio	12.46
Forward PE	12.43
Dividend	0.03 (3.71%)
Ex-Dividend Date	Jun 2, 2025

Volume	376
Average Volume	301
Open	0.7300
Previous Close	0.7300
Day's Range	0.7300 - 0.7300
52-Week Range	0.4340 - 0.7650
Beta	n/a
RSI	54.82
Earnings Date	Aug 28, 2025

About FRA:UK2

Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, wholesale, and sale of medical devices in the People’s Republic of China and internationally. It operates through Medical Device Products, Orthopedic Products, Pharma Packaging Products, Interventional Products, Blood Management Products, and Others segments. The company’s medical device products include safe infusion, clinical nursing, perioperative, endocrine, urinary, rehabilitation system, and extracorporeal circulation solutions; and ...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 1988
• Employees: 12,719
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: UK2

Financial Performance

In 2024, FRA:UK2's revenue was 13.09 billion, a decrease of -1.08% compared to the previous year's 13.23 billion. Earnings were 2.07 billion, an increase of 3.24%.

Financial numbers in CNY